Development of an Updated National Protocol for the Use of Disease-Modifying Treatments in Multiple Sclerosis: A MOH-MOE Steering Committee Initiative in Malaysia
Abstract
Background: There has been an increase in the number of disease-modifying treatments (DMTs) for Multiple Sclerosis (MS). However, treatment accessibility, selection, monitoring, and patient-specific considerations… Read More »Development of an Updated National Protocol for the Use of Disease-Modifying Treatments in Multiple Sclerosis: A MOH-MOE Steering Committee Initiative in Malaysia